Popular Articles

FDA Takes Enforcement Action Against Three New Jersey Dietary Supplement And Protein Powder Manufacturers
The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, has filed a complaint for permanent injunction against Quality Formulation Laboratories, Inc., American Sports Nutrition Inc., Sports Nutrition International LLC and Mohamed S. Desoky, who oversees operations at all three companies.

Joint Clinical Recommendations Developed By The Journal Of Periodontology And The American Journal Of Cardiology
Cardiovascular disease (CVD), the leading killer in the United States, is a major public health issue contributing to 2,400 deaths each day. Periodontal disease, a chronic inflammatory disease that destroys the bone and tissues that support the teeth affects nearly 75 percent of Americans and is the major cause of adult tooth loss. While the prevalence rates of these disease states seem grim, research suggests that managing one disease may reduce the risk for the other.
News of the day
Varian Medical Systems Introduces The PaxScan 3030+ X-Ray Image Detector For Interventional Angiography
Varian Medical Systems, Inc. (NYSE: VAR) X-Ray Products, a world leader in X-ray tubes and supplier of the premier PaxScan® line of digital X-ray image detectors for filmless X-rays, has introduced their first digital imager specifically designed for interventional angiography procedures.
Sexual Health

Evidence Of Harm Has Been Linked To Various Vaccines Challenging Prevailing Public Recommendations

Researchers at the Mayo Clinic set out to determine whether the flu vaccine was effective in reducing the number of hospitalizations for all children, and especially the ones with asthma. The study involved 263 children who were evaluated from six months to 18 years of age, each of whom had had laboratory-confirmed influenza between 1996 to 2006. The investigators determined which children had and had not received the flu vaccine, their asthma status, and who did and did not require hospitalization. Records were reviewed for each subject with influenza-related illness, for flu vaccination preceding the illness, and hospitalization during that illness. "They found that children who had received the flu vaccine had three times the risk of hospitalization, as compared to children who had not received the vaccine. In asthmatic children, there was a significantly higher risk of hospitalization in subjects who received the TIV, as compared to those who did not (p= 0.006)." So, will these disturbing findings--namely, ineffectiveness of the TIV vaccine coupled with evidence of harm--lead the Center for Disease Control and the American Academy of Pediatrics (AAP) to rescind their recommendation for annual influenza vaccination for all children aged six months to 18 years? Or will our public health policy continue to be guided by the entrenched pharmaceutical industry? When evidence suggests that current vaccine recommendations are harming children it is unethical to delay issuing a cautionary advisory by invoking "more studies are needed" to delay action. Public health policy should be guided by the precautionary principle--"Above all, do no harm"--not by business interests. American Thoracic Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):